GR3035265T3 - Determination of tricyclic antidepressant drugs in the presence of interfering substances. - Google Patents

Determination of tricyclic antidepressant drugs in the presence of interfering substances.

Info

Publication number
GR3035265T3
GR3035265T3 GR20010400085T GR20010400085T GR3035265T3 GR 3035265 T3 GR3035265 T3 GR 3035265T3 GR 20010400085 T GR20010400085 T GR 20010400085T GR 20010400085 T GR20010400085 T GR 20010400085T GR 3035265 T3 GR3035265 T3 GR 3035265T3
Authority
GR
Greece
Prior art keywords
compounds
chemical structure
determination
tricyclic antidepressant
antidepressant drugs
Prior art date
Application number
GR20010400085T
Other languages
Greek (el)
Inventor
Maciej Adamczyk
Jeffrey R Fishpaugh
Charles A Harrington
Daryl E Hartter
Robert E Hruska
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of GR3035265T3 publication Critical patent/GR3035265T3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Method and reagents for determining a compound of interest present in a test sample also containing one or more interfering compounds having substantially similar chemical structures, and otherwise analytically indistinguishable from each other, employing a pretreatment reagent capable of selectively modifying the chemical structure of one of the compounds without significantly modifying or altering the chemical structure of the other one of the compounds. The selective modification results in the modified compound having a chemical structure which is substantially dissimilar to the chemical structure of the other one of said compounds wherein the compounds are substantially distinguishable from each other to permit the analytical determination of one or the other of such compounds by immunoassay, high pressure liquid chromatography, and thin layer chromatography techniques, especially for the fluorescent polarization immunoassay determination of tricyclic antidepressant drugs in the presence of phenothiazines.
GR20010400085T 1991-12-13 2001-01-17 Determination of tricyclic antidepressant drugs in the presence of interfering substances. GR3035265T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1991/009389 WO1993012424A1 (en) 1991-12-13 1991-12-13 Determination of tricyclic antidepressant drugs in the presence of interfering substances

Publications (1)

Publication Number Publication Date
GR3035265T3 true GR3035265T3 (en) 2001-04-30

Family

ID=22226048

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400085T GR3035265T3 (en) 1991-12-13 2001-01-17 Determination of tricyclic antidepressant drugs in the presence of interfering substances.

Country Status (9)

Country Link
EP (1) EP0619020B1 (en)
JP (1) JP3169224B2 (en)
AT (1) ATE197504T1 (en)
AU (1) AU658863B2 (en)
DE (1) DE69132467T2 (en)
DK (1) DK0619020T3 (en)
ES (1) ES2153356T3 (en)
GR (1) GR3035265T3 (en)
WO (1) WO1993012424A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352585A (en) * 1993-06-29 1994-10-04 Bio-Rad Laboratories, Inc. System for benzodiazepine detection
US5478729A (en) * 1994-04-28 1995-12-26 Syntex (U.S.A.) Inc. Immunoassay for homocysteine
DE19519973A1 (en) * 1995-05-31 1996-12-05 Boehringer Mannheim Gmbh Interference suppression reagent for the determination of an analyte with a metal complex capable of luminescence
CA2753511A1 (en) * 2009-03-05 2010-09-10 Stt Technologies Inc., A Joint Venture Of Magna Powertrain Inc. And Shw Gmbh Direct control linear variable displacement vane pump
US9114659B2 (en) * 2013-09-23 2015-08-25 Archirazzi, LLC Self-standing desktop calendar
CN107884493B (en) * 2017-11-08 2020-11-24 国家地质实验测试中心 Method for analyzing short-chain chlorinated paraffin in environmental sample by using full-two-dimensional gas chromatography-time-of-flight mass spectrometry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668620A (en) * 1984-02-22 1987-05-26 Syntex (U.S.A.) Inc. Reducing background interference activity in enzyme-label immunoassays
DE3662730D1 (en) * 1985-01-24 1989-05-11 Inst Int Pathologie Cellulaire Immunoassay method for antibodies of different classes in a liquid sample
US4810635A (en) * 1986-04-16 1989-03-07 Miles Inc. Specific binding assays employing label analog to reduce sample interferences
US4820416A (en) * 1987-09-10 1989-04-11 The Royal Institution For The Advancement For Learning (Mcgill University) Removal of bilirubin by the pseudoperoxidase activity of immobilized hemoglobin
US4978632A (en) * 1988-12-15 1990-12-18 Kallestad Diagnostics, Inc. Method of pre-treating samples in peroxidase-catalyzed enzyme assays
EP0411604B1 (en) * 1989-08-04 1995-02-15 Kyowa Medex Co.Ltd. Method and kit for determination of components

Also Published As

Publication number Publication date
DK0619020T3 (en) 2001-02-26
WO1993012424A1 (en) 1993-06-24
DE69132467D1 (en) 2000-12-14
EP0619020B1 (en) 2000-11-08
AU658863B2 (en) 1995-05-04
ATE197504T1 (en) 2000-11-11
JP3169224B2 (en) 2001-05-21
ES2153356T3 (en) 2001-03-01
JPH07501878A (en) 1995-02-23
EP0619020A1 (en) 1994-10-12
DE69132467T2 (en) 2001-06-21
AU1267392A (en) 1993-07-19
EP0619020A4 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
Buchberger Novel analytical procedures for screening of drug residues in water, waste water, sediment and sludge
US5648274A (en) Competitive immunoassay device
Van Emon et al. Bioseparation and bioanalytical techniques in environmental monitoring
CA2098307A1 (en) Determination of tricyclic antidepressant drugs in the presence of interfering substances
KR890010559A (en) Chromatography binding assay device and method
KR880700269A (en) Method and apparatus for separation, mixing and detection of components by specific binding analysis
KR830009486A (en) Analysis method and apparatus of substance
CA2005564A1 (en) Test carrier for the analytical investigation of a sample liquid with the help of a specific binding reaction of two bioaffine binding partners and a corresponding test process
KR890012165A (en) Ion-Capture Analysis Method and Apparatus
ES2001891A6 (en) Multizone analytical element having labeled reagent concentration zone.
ES536947A0 (en) A METHOD FOR THE DETECTION AND DETERMINATION OF AT LEAST ONE LEAGUE IN A SAMPLE SUSPECTED OF CONTAINING SUCH LEAGUE
ATE80735T1 (en) SOLID-SURFACE COLORIMETRIC IMMUNOESSAY, TEST ROD TO BE USED WITH IT AND ITS PREPARATION.
SE7704305L (en) PROCEDURE FOR ANALYSIS OF A BIOLOGICAL LIQUID TEST
GR3035265T3 (en) Determination of tricyclic antidepressant drugs in the presence of interfering substances.
Butler et al. Development of a disposable amperometric immunosensor for the detection of ecstasy and its analogues using screen-printed electrodes
AU2011246529B2 (en) Microfluidic system with sample pretreatment
WO1998026644A3 (en) Confirmatory assays for small molecule drugs
De Silva Analytical strategies for therapeutic monitoring of drugs in biological fluids
DE3785567D1 (en) IMMUNOLOGICAL TEST KIT.
Miller Luminescence measurements on surfaces
Crosby Review of current and future analytical methods for the determination of mycotoxins
EP0359780A1 (en) Solid phase assay by solid phase free site titration
Campíns-Falcó et al. Amphetamine and methamphetamine determinations in biological samples by high performance liquid chromatography. A review
KR890015019A (en) Measurement of arachidonic acid derivatives and kits thereof
WO2002014869A3 (en) Assay method and device for detecting the presence and concentration of analytes

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees